More than 25 researchers and scientists around the world signed a letter expressing fears about the legitimacy of knowledge in a recent paper describing the first clinical trials of the Russian Covid-19 vaccine in The Lancet.
The memo, published on 7 September, is aimed at the authors of a Russian Covid-19 vaccine and the editor of the prestigious medical journal The Lancet.
The authors of the note say that their considerations on knowledge stem from the fact that some knowledge appears to be repeated in a way that defies coincidence, raising considerations that some of the knowledge has been falsified.
For example, all volunteers who won an edition of the vaccine appear to produce exactly the same amount of antibodies 21 and 28 days after injection.
The authors of the note say that definitive conclusions cannot be drawn without the full knowledge of the essay and ask the authors to publish all the knowledge of the experiments.
Lancet’s study was published on 4 September and detailed the effects of an initial two-version clinical trial of The Russian Covid-19 vaccines, and revealed that both vaccines were well tolerated by 76 volunteers.
Although some vaccine trials in the United States and other countries are larger and have collected more data, Russia is the first country in a global race to pass a Covid-19 vaccine.
“Together with a colleagues’ organization, I discovered that the knowledge presented in the recent article on @TheLancet was a little confusing,” wrote Enrico Bucci, a professor of biology at Temple University and the letter. “We want to access the original knowledge. “
Russia was the first country to approve a Covid-19 vaccine, but immediate progression and limited knowledge have raised considerations that the vaccine is not yet in a position for widespread use. Russian President Vladimir Putin announced that the vaccine, dubbed “Sputnik-V”, had been approved on August 11 and said that the country’s medical personnel would begin receiving the vaccine two weeks later. efficacy of the vaccine.
Full policy and updates on the coronavirus
I am an assistant editor of fitness and science at Forbes. Me graduated from UC Berkeley with a master’s degree in journalism and a master’s degree in public fitness, with a
I am an assistant editor of fitness and science at Forbes. Me graduated from UC Berkeley with a master’s degree in journalism and a master’s degree in public aptitude, specializing in infectious diseases. Previously, I was at Johns Hopkins University where I specialized in writing and public aptitude. I have written articles for STAT, Vice, Science News, HealthNewsReview and other publications. At Forbes, I analyze everything from epidemics to new biotechnology companies.